NCT02921399View on ClinicalTrials.gov

Optimal Initiation of Helicobacter Pylori Eradication After Endoscopic Resection for Gastric Neoplasm

CompletedOBSERVATIONAL
Enrollment

149

Participants

Timeline

Start Date

October 10, 2016

Primary Completion Date

March 30, 2021

Study Completion Date

June 30, 2021

Conditions
H.Pylori Eradication Rate
Interventions
OTHER

eradication timing

patients who underwent ESD for gastric neoplasms were randomized to receive early (3-5 days) or late (8-9 weeks) H. pylori eradication therapy after ESD.

Trial Locations (1)

06273

Gangnam Severance Hospital, Yonsei Unversity, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT02921399 - Optimal Initiation of Helicobacter Pylori Eradication After Endoscopic Resection for Gastric Neoplasm | Biotech Hunter | Biotech Hunter